相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Characteristics, outcomes, and risk factors for in-hospital mortality of COVID-19 patients: A retrospective study in Thailand
Thummaporn Naorungroj et al.
FRONTIERS IN MEDICINE (2023)
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019 (COVID-19)
Evan M. Bloch et al.
CLINICAL INFECTIOUS DISEASES (2023)
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
Lindsey Wang et al.
BLOOD REVIEWS (2022)
Admissions in a medical ward and factors independently associated with mortality
Petros Ioannou et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2022)
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis
Jae Hong Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2022)
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature
Marcial Delgado-Fernandez et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2022)
Economic burden of public health care and hospitalisation associated with COVID-19 in China
X. An et al.
PUBLIC HEALTH (2022)
COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study
William K. Gray et al.
THORAX (2022)
Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
Oskar Ljungquist et al.
INFECTIOUS DISEASES (2022)
Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity
Ramona Dolscheid-Pommerich et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
D. J. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Outcomes of B-Cell-Depleted Patients With Coronavirus Disease 2019 Treated With Antispike Monoclonal Antibodies
Zachary A. Yetmar et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Economic Burden of COVID-19: A Systematic Review
Fayolah Richards et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2022)
The genetic and evolutionary determinants of COVID-19 susceptibility
Gaspard Kerner et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2022)
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Livio Pagano et al.
BLOOD (2022)
COVID-19 susceptibility and severity risks in a cross-sectional survey of over 500 000 US adults
Spencer C. Knight et al.
BMJ OPEN (2022)
COVID-19 in Immunocompromised Hosts: What We Know So Far
Monica Fung et al.
CLINICAL INFECTIOUS DISEASES (2021)
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)
Lindsay Kim et al.
CLINICAL INFECTIOUS DISEASES (2021)
Treatment of immunocompromised COVID-19 patients with convalescent plasma
Monica Fung et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Is COVID-19 infection more severe in kidney transplant recipients?
Sophie Caillard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
Albrecht Betrains et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma
Irati Ormazabal Velez et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort
Zoe L. E. van Kempen et al.
JAMA NEUROLOGY (2021)
Impact of rituximab on COVID-19 outcomes
Hannah Levavi et al.
ANNALS OF HEMATOLOGY (2021)
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products
Ariel Kenig et al.
CLINICAL IMMUNOLOGY (2021)
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity
Andreas E. Kremer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19
Bircan Kayaaslan et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed
Dimitrios Daoussis et al.
RHEUMATOLOGY INTERNATIONAL (2021)
Use of convalescent plasma in COVID-19 patients with immunosuppression
Jonathon W. Senefeld et al.
TRANSFUSION (2021)
Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
Gauruv Bose et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A. Thompson et al.
JAMA ONCOLOGY (2021)
Genetic susceptibility of COVID-19: a systematic review of current evidence
SeyedAhmad SeyedAlinaghi et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2021)
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients
Francesco Lanza et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation
Stefano Belli et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery
Evangeline Clark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Disease and healthcare burden of COVID-19 in the United States
Ian F. Miller et al.
NATURE MEDICINE (2020)
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
Jesus Loarce-Martos et al.
RHEUMATOLOGY INTERNATIONAL (2020)
COVID-19 in cancer patients: risk, clinical features, and management
Cuiwei Liu et al.
CANCER BIOLOGY & MEDICINE (2020)
B cell targeted therapies in autoimmune disease
Jennifer L. Barnas et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
Keith A. Sacco et al.
IMMUNOTHERAPY (2018)
Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma
Sohita Dhillon
TARGETED ONCOLOGY (2017)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Gilles Salles et al.
ADVANCES IN THERAPY (2017)
B-cell depletion in the treatment of lupus nephritis
Jon W. Gregersen et al.
NATURE REVIEWS NEPHROLOGY (2012)
The role of B lymphocytes as antigen-presenting cells
Xinjian Chen et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
B cell depletion therapy in autoimmune diseases
Inaki Sanz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Risks and side effects of therapy with plasma and plasma fractions
S MacLennan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2006)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)